Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003134019 | SCV003816319 | likely pathogenic | Familial hypokalemia-hypomagnesemia | 2022-07-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003669354 | SCV004397099 | pathogenic | not provided | 2022-10-31 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with SLC12A3-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala251Hisfs*51) in the SLC12A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A3 are known to be pathogenic (PMID: 20848653, 22009145, 25841442). For these reasons, this variant has been classified as Pathogenic. |